Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-014245
Filing Date
2023-02-24
Accepted
2023-02-24 13:47:37
Documents
73
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_chinahealth.htm   iXBRL 10-K/A 1130054
2 CERTIFICATION f10k2022a1ex31-1_chinahealth.htm EX-31.1 11000
3 CERTIFICATION f10k2022a1ex31-2_chinahealth.htm EX-31.2 15683
4 CERTIFICATION f10k2022a1ex32-1_chinahealth.htm EX-32.1 5313
5 GRAPHIC img_001.jpg GRAPHIC 27225
6 GRAPHIC img_002.jpg GRAPHIC 65745
  Complete submission text file 0001213900-23-014245.txt   5019286

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE chhe-20220630.xsd EX-101.SCH 61670
8 XBRL CALCULATION FILE chhe-20220630_cal.xml EX-101.CAL 34529
9 XBRL DEFINITION FILE chhe-20220630_def.xml EX-101.DEF 215955
10 XBRL LABEL FILE chhe-20220630_lab.xml EX-101.LAB 431945
11 XBRL PRESENTATION FILE chhe-20220630_pre.xml EX-101.PRE 228868
67 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_chinahealth_htm.xml XML 420817
Mailing Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028
Business Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028 011-86-451-51719407
China Health Industries Holdings, Inc. (Filer) CIK: 0001309057 (see all company filings)

EIN.: 860827216 | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-51060 | Film No.: 23665604
SIC: 2834 Pharmaceutical Preparations